Nanologica
Nanologica AB is a Swedish materials technology company specialized in nanoporous silica for chromatography and drug delivery applications. The company develops, manufactures, and markets silica-based media used in preparative chromatography for purifying peptide therapeutics, including insulin and GLP-1 analogues, alongside developing inhalation-based drug delivery platforms. Main revenue drivers include commercial sales of NANOAprep chromatography media and contract development fees. Nanologica serves pharmaceutical manufacturers, biopharmaceutical companies, and life science research laboratories across Europe, Asia, and North America. The company holds a specialized niche position in high-preparative silica chromatography media for peptide purification. Headquartered in Södertälje, Sweden, Nanologica AB is listed on the Nasdaq Main Market.
2 of the funds FundTelligence covers report a position in Nanologica.
- Legal name
- Nanologica AB
- Sector
- Health Care
- Country
- Sweden
- Funds holding it
- 2
Funds holding Nanologica
- Storebrand Sverige Småbolag Plus — Storebrand · 0.0 % (full portfolio disclosed, October 2026)
- Storebrand Sverige Plus — Storebrand · 0.0 % (full portfolio disclosed, October 2026)